Exploring the Management of HPV, Cervical Dysplasia, and Cervical Cancer: From Diagnosis to Survivorship

Costa Mesa, CA US
February 29, 2024

Exploring the Management of HPV, Cervical Dysplasia, and Cervical Cancer: From Diagnosis to Survivorship Overview

Cervical Cancer is the fourth most common cancer in women globally. Multiple factors play a role in the effective treatment and management of patients diagnosed with cervical cancer. There exists a tremendous amount of data which clinicians require to obtain in order to remain abreast of the most effective strategies to treat. 

This dinner meeting will discuss the evaluation and management of high-risk HPV cervical dysplasia and early stage cervical cancer; as well as the evolving treatment paradigm for the management of metastatic or recurrent cervical cancer.  Additionally, this program will profile survivorship concerns such as the optimization of functional recovery of strength after radical hysterectomy and chemosensitizing radiation and urinary incontinence and pelvic organ prolapse after treatment for pelvic pre-cancer and/or cancer.

Target Audience

This educational activity is directed towards family practicioners, internal medicine, gynecology and obstetrics , medical oncologists, radiation oncologists, gynecologic oncologists and other allied heathcare providers interested in the topic of cervical cancer.

Learning Objectives

  • Outline management strategies for HPV associated high-grade cervical dysplasia/precancer.
  • Distinguish which time points in cervical cancer management should include the use of immunotherapy, anti-body drug conjugates and radiation.
  • Integrate functional recovery strategies with phsyical medicine and rehabilitation to ensure adequate recover of strength and well-being after surgery or chemoradiation.
  • Identify and assess pelvic organ prolapse and urniary incontinence after pelvic cancer treatment.
  • Outline surviviorship strategies to improve quality of life for patients treated for high-grade cervical precancer and cervical cancer.
  • Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Activity summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this Exploring the Management of HPV, Cervical Dysplasia, and Cervical Cancer: From Diagnosis to Survivorship for a maximum of 1.50 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Attendance
Activity opens: 
01/19/2024
Activity expires: 
03/08/2024
Event starts: 
02/29/2024 - 6:30pm PST
Event ends: 
02/29/2024 - 8:00pm PST
Cost:
$1.00
Avenue of the Arts Costa Mesa, a Tribute Portfolio Hotel
3350 Avenue of the Arts
Costa Mesa, CA 92626
United States

Event Parking:

- Free Self Parking
- Discounted Valet Parking: $10

Faculty

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™ 1.5

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.5 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
 

DISCLOSURE INFORMATION: 

This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.

As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any ineligible company. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months, that could create a conflict of interest, and an "ineligible company" as any entity producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Any potential conflicts relative to the previous disclosure have been resolved.

Written disclosure of all such relevant financial relationships will be provided in the activity handout and/or syllabus. Any potential conflicts relative to the previous disclosure have been resolved.

City of Hope further encourages faculty/authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.

The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this Exploring the Management of HPV, Cervical Dysplasia, and Cervical Cancer: From Diagnosis to Survivorship for a maximum of 1.50 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Attendance

Price

Cost:
$1.00
Please login or register to take this activity.

You must be logged in to your account to complete your registration. 

Under "Registrant Type" dropdown (above), select your Registration Fee depending on your profession and click "Add to Cart". Follow the payment prompts. 

You will receive an email confirmation once you are registered.  

Registrant Type

Registration

Physician (Dinner Included)$0
Nurse/Other Allied Health Care Provider (Dinner Included)$0
Student/Resident/Fellow (Dinner Included)$0
*Industry/Commercial Employee Attendee (Dinner Included)$300

Registration includes meeting, dinner, and CME Credit.

Last day to register is on Thursday, February 22, 2024.
Last day to to cancel is on Monday, February 26, 2024.

For questions, contact the Department of Continuing Medical Education at cme@coh.org or 626-218-5622 

*Industry/Commercial Employee Attendee is defined as any individual employed by a for-profit, including biotech, financial and pharmaceutical.